EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the ...
Revolutionary retinal implant restores central vision in 80% of patients with advanced macular degeneration, offering hope ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback